RxDoctor Payments Data

Raza Khan, MD

Pain Medicine · Charlotte, NCNPI 1407067929

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (57.7%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Abbott at 49.9% of the total. Reporting peaked in 2024 at $7,132 and has fallen 67.4% since, to $2,323 in 2025.

$12,279in general payments, 2019–2025

Across 265 payments — averaging $46.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$6K
  • Boston Scientific$5K
  • Medtronic$646
  • Stimwave Technologies Incorporated$176
  • SPR Therapeutics, Inc$99
  • Forte Bio-pharma LLC$73
  • plus $211 from 8 others

What the payments were for

  • Speaking & faculty fees$4,35035%
  • Travel & lodging$8447%
  • Food & beverage$7,08458%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,279 in reported general payments places this provider in the 80th percentile of 182 pain medicine providers in North Carolina.

See all pain medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$189,905
Medicare patients
462
Services billed
2,131

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Xtampza ErOxycodone Myristate43$25,759
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen687$20,207
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen706$17,046
Nucynta ErTapentadol Hcl14$14,011
Diclofenac Sodium132$13,556
OxycontinOxycodone Hcl21$10,271
Celecoxib304$8,830
Buprenorphine23$5,720
Fentanyl54$5,179
Gabapentin207$5,131
Pregabalin96$4,140
Oxycodone Hcl253$4,022
Lidocaine22$3,735
Methocarbamol135$3,557
Morphine Sulfate ErMorphine Sulfate119$3,396

Paid to pharmacies, not to this prescriber.

Other pain medicine in Charlotte

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →